English
Insider transactions
EDGARDecoy Therapeutics Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 2 transactions, 27 shares
- Sum of shares × price per share: 17.2719
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–12 of 12
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 Filed 2026-09-02 | Burleson Tess Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,000 | 0 | — | 2,002 | Direct (D) | No | F1, F2
| Open filing 0001769749-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | PIERCE FREDERICK II Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 33,455 | 0 | — | 34,844 | Direct (D) | No | F1, F2
| Open filing 0001229055-26-000002 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | Lammers Paul Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,000 | 0 | — | 2,001 | Direct (D) | No | F1, F2
| Open filing 0001457289-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | Rosenblum Mark J Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,682 | 0 | — | 11,363 | Direct (D) | No | F1, F2
| Open filing 0001329154-26-000003 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | Lieber Jonathan I Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,000 | 0 | — | 2,002 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-380584 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | Gauthier Patricia G. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,000 | 0 | — | 2,000 | Direct (D) | No | F1
| Open filing 0002148287-26-000002 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | HANISH ARNOLD C Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000 | 0 | — | 3,418 | Direct (D) | No | F1, F2
| Open filing 0001233253-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | Marschel Peter Klaus Officer: Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,900 | 0 | — | 3,900 | Direct (D) | No | F1
| Open filing 0002079859-26-000002 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | Hibner Barbara Louise Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,216 | 0 | — | 4,216 | Direct (D) | No | F1
| Open filing 0002079512-26-000002 Read from the filing’s XML Dispute this row |
| 2026-08-31 Filed 2026-09-02 | McVicar William K. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,000 | 0 | — | 3,002 | Direct (D) | No | F1, F2
| Open filing 0001634368-26-000003 Read from the filing’s XML Dispute this row |
| 2025-12-30 Filed 2026-01-02 | HANISH ARNOLD C Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15 | 0.6397 | 9.5955Derived: shares × price per share. Exact value 9.5955. | 5,000 | Indirect (I) By Arnold C. Hanish Trust | No | — | Open filing 0001615219-26-000004 Read from the filing’s XML Dispute this row |
| 2025-12-30 Filed 2026-01-02 | HANISH ARNOLD C Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12 | 0.6397 | 7.6764Derived: shares × price per share. Exact value 7.6764. | 0 | Direct (D) | No | — | Open filing 0001615219-26-000004 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–6 of 6
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC Partly reported under another manager | 32,000 SH | 63,040 dollars | Not in the prior quarter’s filings read | Open filing 0000312272-26-000024 Filed 2026-11-02 Dispute this row |
| UBS Group AG Partly reported under another manager | 4,525 SH | 8,914 dollars | Higher by 4,500 Prior quarter: 25 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,034 SH | 7,947 dollars | Unchanged Prior quarter: 4,034 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 3,735 SH | 7,358 dollars | Higher by 3,479 Prior quarter: 256 | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| SBI Securities Co., Ltd. | 111 SH | 219 dollars | Not in the prior quarter’s filings read | Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 80 SH | 170 dollars | Not in the prior quarter’s filings read | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Caitong International Asset Management Co., Ltd 2 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| CVI Investments, Inc. Common Stock, $0.0001 par value per share | 9.9 | 72,717 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001649553-26-000138 Dispute this row |
| Heights Capital Management, Inc. Common Stock, $0.0001 par value per share | 9.9 | 72,717 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001649553-26-000138 Dispute this row |
| Armistice Capital, LLC Common Stock, par value $0.0001 per share | 9.99 | 65,503.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001172661-26-003569 Dispute this row |
| Steven Boyd Common Stock, par value $0.0001 per share | 9.99 | 65,503.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001172661-26-003569 Dispute this row |
| CVI Investments, Inc. Common Stock, $0.0001 par value per share | 9.9 | 708,565 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001649553-26-000025 Dispute this row |
| Heights Capital Management, Inc. Common Stock, $0.0001 par value per share | 9.9 | 708,565 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001649553-26-000025 Dispute this row |
| Mitchell P. Kopin Common Stock, par value $0.0001 per share | 4.99 | 187,295.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0001213900-25-111043 Dispute this row |
| Daniel B. Asher Common Stock, par value $0.0001 per share | 4.99 | 187,295.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0001213900-25-111043 Dispute this row |
| Intracoastal Capital LLC Common Stock, par value $0.0001 per share | 4.99 | 187,295.00 | 11/12/2025 Filed 2025-11-14 | SCHEDULE 13G | Open filing 0001213900-25-111043 Dispute this row |
| CVI Investments, Inc. Common Stock, $0.0001 par value per share | 9.9 | 362,499 | 11/11/2025 Filed 2025-11-18 | SCHEDULE 13G | Open filing 0001649553-25-000209 Dispute this row |
| Heights Capital Management, Inc. Common Stock, $0.0001 par value per share | 9.9 | 362,499 | 11/11/2025 Filed 2025-11-18 | SCHEDULE 13G | Open filing 0001649553-25-000209 Dispute this row |
| C/M Capital Master Fund, LP Common Stock, par value $0.0001 per share | 0 | 0.00 | 10/07/2025 Filed 2025-10-14 | SCHEDULE 13G | Open filing 0000902664-25-004399 Dispute this row |
| C/M CAPITAL PARTNERS, LP Common Stock, par value $0.0001 per share | 0 | 0.00 | 10/07/2025 Filed 2025-10-14 | SCHEDULE 13G | Open filing 0000902664-25-004399 Dispute this row |
| Thomas Walsh Common Stock, par value $0.0001 per share | 0 | 0.00 | 10/07/2025 Filed 2025-10-14 | SCHEDULE 13G | Open filing 0000902664-25-004399 Dispute this row |
| Jonathan Juchno Common Stock, par value $0.0001 per share | 0 | 0.00 | 10/07/2025 Filed 2025-10-14 | SCHEDULE 13G | Open filing 0000902664-25-004399 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,687,210 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 103,592 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.